GABAergic/glutamatergic Imbalance Relative to Excessive Neuroinflammation in Autism Spectrum Disorders

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2014 Nov 20

PMID 25407263

Citations 95

Authors

Afaf El-Ansary

Laila Al-Ayadhi

Affiliations

Soon will be listed here.

Abstract

Background: Autism spectrum disorder (ASD) is characterized by three core behavioral domains: social deficits, impaired communication, and repetitive behaviors. Glutamatergic/GABAergic imbalance has been found in various preclinical models of ASD. Additionally, autoimmunity immune dysfunction, and neuroinflammation are also considered as etiological mechanisms of this disorder. This study aimed to elucidate the relationship between glutamatergic/ GABAergic imbalance and neuroinflammation as two recently-discovered autism-related etiological mechanisms.

Methods: Twenty autistic patients aged 3 to 15 years and 19 age- and gender-matched healthy controls were included in this study. The plasma levels of glutamate, GABA and glutamate/GABA ratio as markers of excitotoxicity together with TNF-α, IL-6, IFN-γ and IFI16 as markers of neuroinflammation were determined in both groups.

Results: Autistic patients exhibited glutamate excitotoxicity based on a much higher glutamate concentration in the autistic patients than in the control subjects. Unexpectedly higher GABA and lower glutamate/GABA levels were recorded in autistic patients compared to control subjects. TNF-α and IL-6 were significantly lower, whereas IFN-γ and IFI16 were remarkably higher in the autistic patients than in the control subjects.

Conclusion: Multiple regression analysis revealed associations between reduced GABA level, neuroinflammation and glutamate excitotoxicity. This study indicates that autism is a developmental synaptic disorder showing imbalance in GABAergic and glutamatergic synapses as a consequence of neuroinflammation.

Citing Articles

Gamma-aminobutyric acid and glutamate system dysregulation in a small population of Egyptian children with autism spectrum disorder.

Meguid N, Ismail S, Anwar M, Hashish A, Semenova Y, Abdalla E Metab Brain Dis. 2025; 40(3):146.

PMID: 40080228 DOI: 10.1007/s11011-025-01557-2.

From Homeostasis to Neuroinflammation: Insights into Cellular and Molecular Interactions and Network Dynamics.

Muller L, Di Benedetto S, Muller V Cells. 2025; 14(1.

PMID: 39791755 PMC: 11720143. DOI: 10.3390/cells14010054.

Increased Serotonin Levels and Unchanged Glutamate and GABA Levels in Thalamic Microdialysates Despite Reduced Cell Numbers in a Valproic Acid-Induced Autism Model.

Ay H, Horata E, Oncu Kaya E, Korkmaz O Neurochem Res. 2024; 50(1):45.

PMID: 39636522 DOI: 10.1007/s11064-024-04299-2.

Omic characterizing and targeting gut dysbiosis in children with autism spectrum disorder: symptom alleviation through combined probiotic and medium-carbohydrate diet intervention - a pilot study.

Li Y, Hu W, Lin B, Ma T, Zhang Z, Hu W Gut Microbes. 2024; 16(1):2434675.

PMID: 39632378 PMC: 11622613. DOI: 10.1080/19490976.2024.2434675.

Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases.

Bortoletto R, Piscitelli F, Basaldella M, Scipioni C, Comacchio C, Fiorino R Front Psychiatry. 2024; 15:1463849.

PMID: 39502301 PMC: 11536324. DOI: 10.3389/fpsyt.2024.1463849.

References

Morrow E, Yoo S, Flavell S, Kim T, Lin Y, Hill R . Identifying autism loci and genes by tracing recent shared ancestry. Science. 2008; 321(5886):218-23. PMC: 2586171. DOI: 10.1126/science.1157657. View

Dingledine R, Borges K, Bowie D, Traynelis S . The glutamate receptor ion channels. Pharmacol Rev. 1999; 51(1):7-61. View

Fatemi S, Folsom T, Reutiman T, Thuras P . Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum. 2008; 8(1):64-9. PMC: 2732344. DOI: 10.1007/s12311-008-0075-3. View

Li X, Chauhan A, Sheikh A, Patil S, Chauhan V, Li X . Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009; 207(1-2):111-6. PMC: 2770268. DOI: 10.1016/j.jneuroim.2008.12.002. View

Canitano R . Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatry. 2006; 16(1):61-6. DOI: 10.1007/s00787-006-0563-2. View

Neher E . Vesicle pools and Ca2+ microdomains: new tools for understanding their roles in neurotransmitter release. Neuron. 1998; 20(3):389-99. DOI: 10.1016/s0896-6273(00)80983-6. View

Szabo B, Wallmichrath I, Mathonia P, Pfreundtner C . Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience. 2000; 97(1):89-97. DOI: 10.1016/s0306-4522(00)00036-1. View

Mizuno T, Zhang G, Takeuchi H, Kawanokuchi J, Wang J, Sonobe Y . Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor. FASEB J. 2008; 22(6):1797-806. DOI: 10.1096/fj.07-099499. View

Pickering M, Cumiskey D, OConnor J . Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol. 2005; 90(5):663-70. DOI: 10.1113/expphysiol.2005.030734. View

10.

Ghosh M, Yang Y, Rothstein J, Robinson M . Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes. J Neurosci. 2011; 31(25):9159-69. PMC: 3138498. DOI: 10.1523/JNEUROSCI.0302-11.2011. View

11.

Wei H, Zou H, Sheikh A, Malik M, Dobkin C, Brown W . IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflammation. 2011; 8:52. PMC: 3114764. DOI: 10.1186/1742-2094-8-52. View

12.

Fatemi S, Halt A, Stary J, Kanodia R, Schulz S, Realmuto G . Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry. 2002; 52(8):805-10. DOI: 10.1016/s0006-3223(02)01430-0. View

13.

Guptill J, Booker A, Gibbs T, Kemper T, Bauman M, Blatt G . [3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study. J Autism Dev Disord. 2006; 37(5):911-20. DOI: 10.1007/s10803-006-0226-7. View

14.

Suresh Babu S, Shareef M, Shetty A, Shetty K . HPLC method for amino acids profile in biological fluids and inborn metabolic disorders of aminoacidopathies. Indian J Clin Biochem. 2012; 17(2):7-26. PMC: 3454125. DOI: 10.1007/BF02867967. View

15.

M Durand C, Betancur C, Boeckers T, Bockmann J, Chaste P, Fauchereau F . Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 2006; 39(1):25-7. PMC: 2082049. DOI: 10.1038/ng1933. View

16.

Han S, Tai C, Jones C, Scheuer T, Catterall W . Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism. Neuron. 2014; 81(6):1282-1289. PMC: 4079471. DOI: 10.1016/j.neuron.2014.01.016. View

17.

Owens D, Kriegstein A . Is there more to GABA than synaptic inhibition?. Nat Rev Neurosci. 2002; 3(9):715-27. DOI: 10.1038/nrn919. View

18.

Abrahams B, Geschwind D . Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet. 2008; 9(5):341-55. PMC: 2756414. DOI: 10.1038/nrg2346. View

19.

Fagni L, Ango F, Perroy J, Bockaert J . Identification and functional roles of metabotropic glutamate receptor-interacting proteins. Semin Cell Dev Biol. 2004; 15(3):289-98. DOI: 10.1016/j.semcdb.2003.12.018. View

20.

McGeer P, McGeer E . Local neuroinflammation and the progression of Alzheimer's disease. J Neurovirol. 2002; 8(6):529-38. DOI: 10.1080/13550280290100969. View